MIT Holding, Inc. (MITD) Pioneers Single-Source Ap
Post# of 36
Posted On: 03/24/2015 5:13:09 PM
MIT Holding, Inc. (MITD) Pioneers Single-Source Approach to Revolutionize Outpatient Medical Home Medical Care
Los Angeles-based MIT Holding, operating through its network of accredited agents, facilitators and contractual obligations, has developed a single-source approach geared to simplify professional outpatient medical care for the roughly 135 million people discharged from inpatient hospital care in the U.S. each year.
The company provides a comprehensive set of outpatient services designed to accelerate patient recovery by providing them with ultimate convenience and by reducing stress associated with coordinating and receiving appropriate products and care. MIT’s services are provided within the comfort of the patient’s home and include ambulatory infusion therapies, home infusion services and medical equipment delivery.
Additionally, because MIT is in compliance with major U.S. health insurance requirements, the company is able to direct bill and receive payments from carriers on behalf of patients, agents and facilitators. The result is a seamless transition for patient needs from hospital discharge to complete home recovery.
MIT has completed beta tests on its single-source concept, successfully providing medical recovery services from the point of discharge from the hospital or medical facility to full recovery. The company’s initiative is to use the testing as a catalyst to grow its presence nationwide and expand through one strategic acquisition per quarter.
In support of its core services, MIT also provides expert legal, accounting, advisory and educational services to physicians, medical centers, hospitals, small and large businesses regarding the Affordable Care Act.
Demonstrative of the company’s flexibility and progressive insight to the healthcare industry, MIT also offers travel and transportation services of medically challenged patients for medical needs and personal travel. Furthermore, through its contracts, MIT is approved to conduct and administer FDA clinical trials.
Together, these services are the foundation of MIT’s mission to provide custom prescription solutions in a variety of methods while generating multiple revenue streams and increasing shareholder value.
Thanks to a strategic and successful reorganization initiative in 2014, MIT is positioned to achieve 32% minimum net profits and has maintained profitability in its fiscal second and third quarters. This profitability underscores the company’s unique concept and its relevance to the health services industry.
For more information, visit www.mitholdinginc.com
Please see disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.com
Los Angeles-based MIT Holding, operating through its network of accredited agents, facilitators and contractual obligations, has developed a single-source approach geared to simplify professional outpatient medical care for the roughly 135 million people discharged from inpatient hospital care in the U.S. each year.
The company provides a comprehensive set of outpatient services designed to accelerate patient recovery by providing them with ultimate convenience and by reducing stress associated with coordinating and receiving appropriate products and care. MIT’s services are provided within the comfort of the patient’s home and include ambulatory infusion therapies, home infusion services and medical equipment delivery.
Additionally, because MIT is in compliance with major U.S. health insurance requirements, the company is able to direct bill and receive payments from carriers on behalf of patients, agents and facilitators. The result is a seamless transition for patient needs from hospital discharge to complete home recovery.
MIT has completed beta tests on its single-source concept, successfully providing medical recovery services from the point of discharge from the hospital or medical facility to full recovery. The company’s initiative is to use the testing as a catalyst to grow its presence nationwide and expand through one strategic acquisition per quarter.
In support of its core services, MIT also provides expert legal, accounting, advisory and educational services to physicians, medical centers, hospitals, small and large businesses regarding the Affordable Care Act.
Demonstrative of the company’s flexibility and progressive insight to the healthcare industry, MIT also offers travel and transportation services of medically challenged patients for medical needs and personal travel. Furthermore, through its contracts, MIT is approved to conduct and administer FDA clinical trials.
Together, these services are the foundation of MIT’s mission to provide custom prescription solutions in a variety of methods while generating multiple revenue streams and increasing shareholder value.
Thanks to a strategic and successful reorganization initiative in 2014, MIT is positioned to achieve 32% minimum net profits and has maintained profitability in its fiscal second and third quarters. This profitability underscores the company’s unique concept and its relevance to the health services industry.
For more information, visit www.mitholdinginc.com
Please see disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.com
(0)
(0)